About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Pennsylvania | 30,750 Studies Near You

Clinical TrialsPennsylvania

Clinical Trials in Pennsylvania

Discover 30,750 clinical trials near Pennsylvania. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3081-3100 of 30,750 trials

TerminatedWeight-based Dosing in Hemophilia AHemophilia A is an inherited (genetic) disease where a protein, factor VIII (FVIII), which promotes blood clotting is missing or does not work properly.NCT02586012·Pittsburgh, Pennsylvania CompletedTrastuzumab Plus Chemotherapy in Treating Patients With Advanced Non-small Cell Lung CancerRATIONALE: Monoclonal antibodies can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells.NCT00003881·Scottsdale, Arizona and 70 others

Find Trials by Condition in Pennsylvania

Breast Cancerin Pennsylvania Lung Cancerin Pennsylvania Prostate Cancerin Pennsylvania Colorectal Cancerin Pennsylvania Melanomain Pennsylvania Leukemiain Pennsylvania Lymphomain Pennsylvania Pancreatic Cancerin Pennsylvania Ovarian Cancerin Pennsylvania Brain Cancerin Pennsylvania

Data from ClinicalTrials.govTerms

Active not recruitingEffect of (TaVNS) on Anxiety and Brain Function in Distressed Health Care WorkersThe purpose of this research is to measure alterations in anxiety and brain activity associated with the use of an approved health device called Transauricular Vagal Nerve…NCT05132881·Philadelphia, Pennsylvania

WithdrawnExamining the Impact of Transcranial Focused Ultrasound (tFUS) on Reward Neural CircuitryThe investigators aim to examine the immediate effect of transcranial focused ultrasound (tFUS) on brain activity and emotions in healthy adults as a first stage toward…NCT05875181·Pittsburgh, Pennsylvania

TerminatedMetformin Hydrochloride and Doxycycline in Treating Patients With Head and Neck Squamous Cell CarcinomaThis randomized phase II trial studies how well metformin hydrochloride and doxycycline work in treating patients with head and neck squamous cell carcinoma that can be removed by…NCT03076281·Philadelphia, Pennsylvania

CompletedDose Ranging, Safety and Tolerability of TOPROL-XL® Extended-Release Tablets in Hypertensive Pediatric SubjectsThis was a 4-week, multicenter, double-blind, placebo-controlled, randomized, parallel-group study to determine the antihypertensive dose range, efficacy, safety and tolerability…NCT00255528·Little Rock, Arkansas and 30 others

UnknownIndomethacin Versus Placebo in Women With Preterm Premature Rupture of Membranes (PPROM)The purpose of this study is to determine if the short term use of indomethacin will reduce the number of women delivering within 48 hours when given to women with preterm…NCT00466128·Philadelphia, Pennsylvania

CompletedA Phase 1b Study of the Safety of REN001 in Patients With Fatty Acid Oxidation DisordersThe purpose of this Phase 1b study is to assess REN001 safety in subjects with fatty acid oxidation disorders.NCT03833128·Aurora, Colorado and 6 others

CompletedBortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition DiseaseRATIONALE: Giving bortezomib together with melphalan and dexamethasone may be an effective treatment for primary amyloidosis and light chain deposition disease.NCT00520767·Denver, Colorado and 6 others

No longer availableTreatment With UX007 for a Single Patient With GLUT1 Deficiency SyndromeThis treatment plan is intended for the use of UX007 (triheptanoin) in the treatment of a single patient with Glucose Transporter 1 (GLUT1) Deficiency Syndrome.NCT02968953·Pittsburgh, Pennsylvania

TerminatedHydroxychloroquine in Individuals At-risk for Type 1 Diabetes MellitusThe study is a 2-arm, double blinded, multicenter, 2:1 randomized, placebo controlled clinical trial.NCT03428945·Los Angeles, California and 50 others

CompletedVolume Versus Concentration: Clinical Effectiveness of Single Shot Quadrates Lumborum Block Using Either a High Volume/Low Concentration or Low Volume/High Concentration Injectate for Total Hip Arthroplasty.There is Controversy about what is more critical volume or concentration to achieve an optimum analgesic treatment with quadratus lumborum block.NCT04259645·Pittsburgh, Pennsylvania and 1 other

CompletedActhar in Treatment of Refractory Dermatomyositis and PolymyositisThe purpose of this research study is to evaluate the effectiveness of the study drug, ACTH Gel in people diagnosed with dermatomyositis a disease that causes muscle weakness and…NCT01906372·Great Neck, New York and 1 other

TerminatedEvaluation and Treatment of Copper/Zinc Imbalance in Children With AutismThere are two phases to the study.NCT00325572·Hershey, Pennsylvania

CompletedVascular Endothelial Growth Factor VEGF Trap-Eye:Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration(AMD)This study is a phase 3, double-masked, randomized, study of the efficacy and safety of VEGF Trap-Eye in patients with neovascular age-related macular degeneration.NCT00509795·Birmingham, Alabama and 187 others

TerminatedGSK1605786A in the Maintenance of Remission in Subjects With Crohn's DiseaseA randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of two doses (500 mg once daily and 500 mg twice daily) of GSK1605786A in maintaining…NCT01316939·Little Rock, Arizona and 255 others

CompletedMonoclonal Antibody Against PCSK9 to Reduce Elevated Low-density Lipoprotein Cholesterol (LDL-C) in Adults Currently Not Receiving Drug Therapy for Easing Lipid LevelsThe primary objective was to evaluate the effect of 12 weeks of subcutaneous evolocumab (AMG 145) every 2 weeks (Q2W) or every 4 weeks (Q4W), compared with placebo, on the percent…NCT01375777·Birmingham, Alabama and 57 others

CompletedAn Open-label Study (OLE) for Non-responders of VRDN-001-101 and VRDN-001-301The investigational drug, VRDN-001, is a monoclonal antibody that inhibits the activity of a cell surface receptor called insulin-like growth factor-1 receptor (IGF-1R).NCT06179875·Los Angeles, California and 44 others

CompletedAn Evaluation of a Web-based Intervention Program for Parents and Teens to Promote Safe DrivingThe long-term goal of this research is to increase safe driving among novice teen drivers by increasing the quantity, quality and diversity of driving practice while accompanied…NCT01498575·Philadelphia, Pennsylvania

CompletedA 3-Month Open-Label Safety and Efficacy Study of TNX-102 SL Tablets in Fibromyalgia PatientsThis is a Phase 3, open-label, extension trial designed to evaluate the long term safety and efficacy over 3 months of TNX-102 SL tablets taken daily at bedtime for the treatment…NCT02589275·Birmingham, Alabama and 32 others

PreviousPage 155 of 1538Next

Diabetes

in Pennsylvania

Heart Diseasein Pennsylvania